Evidence map›Paper›PMID 29867222›Full record

ArticleNature genetics2018

The transcription factor Grainy head primes epithelial enhancers for spatiotemporal activation by displacing nucleosomes.

Jelle Jacobs, Mardelle Atkins, Kristofer Davie, Hana Imrichova, Lucia Romanelli, Valerie Christiaens, Gert Hulselmans, Delphine Potier, Jasper Wouters, Ibrahim I Taskiran and 6 more

Abstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. KMT2C and KMT2D amplify GRHL2-driven enhancer activation.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jelle JacobsVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0002-8985-9449
Mardelle AtkinsVIB Center for Cancer Biology, Leuven, Belgium.
Kristofer DavieVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.
Hana ImrichovaVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.
Lucia RomanelliVIB Center for Cancer Biology, Leuven, Belgium.
Valerie ChristiaensVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.
Gert HulselmansVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2205-1899
Delphine PotierVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0003-1684-9888
Jasper WoutersVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0002-7129-2990
Ibrahim I TaskiranBogazici University, Molecular Biology and Genetics, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5077-5264
Giulia PacielloPolitecnico di Torino, Automatics and Informatics, Turin, Italy.
Carmen B González-BlasVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.
Duygu KoldereVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.
Sara AibarVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium.ORCID http://orcid.org/0000-0001-6104-7134
Georg HalderVIB Center for Cancer Biology, Leuven, Belgium.
Stein AertsVIB Center for Brain and Disease Research, Laboratory of Computational Biology, Leuven, Belgium. stein.aerts@kuleuven.vib.be.ORCID http://orcid.org/0000-0002-8006-0315

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
European Research Council 724226NIH HHS P40 OD018537
6 · The paper itself

Abstract

Transcriptional enhancers function as docking platforms for combinations of transcription factors (TFs) to control gene expression. How enhancer sequences determine nucleosome occupancy, TF recruitment and transcriptional activation in vivo remains unclear. Using ATAC-seq across a panel of Drosophila inbred strains, we found that SNPs affecting binding sites of the TF Grainy head (Grh) causally determine the accessibility of epithelial enhancers. We show that deletion and ectopic expression of Grh cause loss and gain of DNA accessibility, respectively. However, although Grh binding is necessary for enhancer accessibility, it is insufficient to activate enhancers. Finally, we show that human Grh homologs-GRHL1, GRHL2 and GRHL3-function similarly. We conclude that Grh binding is necessary and sufficient for the opening of epithelial enhancers but not for their activation. Our data support a model positing that complex spatiotemporal expression patterns are controlled by regulatory hierarchies in which pioneer factors, such as Grh, establish tissue-specific accessible chromatin landscapes upon which other factors can act.

Indexed as

AnimalsAnimals, Genetically ModifiedBinding SitesCell Line, TumorChromatinDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsEnhancer Elements, GeneticEpithelial CellsGene Expression Regulation, DevelopmentalHumansMCF-7 CellsNucleosomesPolymorphism, Single NucleotideTranscriptional ActivationChromatinDNA-Binding ProteinsDrosophila Proteinsgrh protein, DrosophilaNucleosomesTranscription Factors

Identifiers

PMID29867222
PMCPMC6031307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.